Results 31 to 40 of about 23,381 (306)

Medication-Related Osteonecrosis: Why the Jawbone?

open access: yesDentistry Journal, 2023
Medication-related osteonecrosis of the jaw (MRONJ) has emerged as a complication of anti-resorptive medications. Despite its low incidence rate, this problem has gained attention in recent years due to its devastating consequences and lack of preventive
Sydney Kuehn   +2 more
doaj   +1 more source

Challenges and Controversies in the Diagnosis of MRONJ [PDF]

open access: yes, 2019
Medication-related osteonecrosis of the jaw (MRONJ) is a relatively rare but potentially seriousand debilitating complication [...
Campisi, Giuseppina, Fede, Olga Di
core   +1 more source

Cost-utility of adjuvant zoledronic acid in patients with breast cancer and low estrogen levels [PDF]

open access: yes, 2015
BACKGROUND: Adjuvant zoledronic acid (za) appears to improve disease-free survival (dfs) in women with early-stage breast cancer and low levels of estrogen (lle) because of induced or natural menopause.
Lamond, Nathan W D   +3 more
core   +1 more source

Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report

open access: yesJournal of Medical Case Reports, 2011
Introduction Osteonecrosis of the jaw is a serious side effect in patients receiving nitrogen-containing bisphosphonates intravenously due to malignant diseases.
Ehrenfeld Michael   +3 more
doaj   +1 more source

The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw. [PDF]

open access: yesPLoS ONE, 2015
Validation of claims-based algorithms to identify serious hypersensitivity reactions and osteonecrosis of the jaw has not been performed in large osteoporosis populations.
Nicole C Wright   +7 more
doaj   +1 more source

Histology of the Oral Mucosa in Patients With BRONJ at III Stage: A Microscopic Study Proves the Unsuitability of Local Mucosal Flaps. [PDF]

open access: yes, 2013
BACKGROUND: Bisphosphonate Osteonecrosis of the Jaw (BRONJ) is a newly recognized condition reported in patients treated with aminobisphosphonates (BF).
CORDOVA, Adriana   +3 more
core   +1 more source

Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates [PDF]

open access: yes, 2017
Osteonecrosis of the jaw (MRONJ) linked to bisphosphonate treatment has specific characteristics that render its therapeutic management challenging for clinicians.
Bermúdez Bejarano, Elena Beatriz   +6 more
core   +1 more source

Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate

open access: yesAutopsy and Case Reports, 2021
Although uncommon in patients under oral therapy, bisphosphonate-related osteonecrosis of the jaw (BRONJ) can be a very severe issue. Early intervention with surgical resection should be the preferable method of treating any stage of the disease ...
Marília A. Figueiredo   +2 more
doaj  

[Osteonecrosis of the jaw].

open access: yesEndokrynologia Polska, 2011
The paper concerns osteonecrosis of the jaw (ONJ). It is a rare but serious clinical condition. It can develop in patients treated in oncologic doses with bisphosphonates but also with denosumab. In osteoporosis ONJ seems to be very rare. Definition, pathogenesis, risk factors, prevention and treatment, and the frequency of ONJ are presented.
  +7 more sources

Spontaneous bone regeneration in resected non-continuous mandible due to medication-related osteonecrosis of the jaw

open access: yesJournal of the Korean Association of Oral and Maxillofacial Surgeons, 2021
Few cases of spontaneous bone regeneration after extensive resection of the jaw bone have been reported, but it is more common in young adults or children. In this case, we report spontaneous bone healing in a 73-year-old female patient.
A. Esen, Gokhan Gurses, Sebnem Akkulah
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy